Grantham, Mayo, Van Otterloo & Co (GMO)’s Ashland ASH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,274
Closed -$291K 721
2021
Q1
$291K Sell
3,274
-426
-12% -$36.7K ﹤0.01% 785
2020
Q4
$293K Buy
+3,700
New +$280K ﹤0.01% 753
2019
Q3
Sell
-19,000
Closed -$1.52M 729
2019
Q2
$1.52M Sell
19,000
-6,100
-24% -$471K 0.01% 483
2019
Q1
$1.96M Sell
25,100
-800
-3% -$61.6K 0.01% 396
2018
Q4
$1.84M Buy
+25,900
New +$2M 0.01% 291

Other funds holding ASH

Grantham, Mayo, Van Otterloo & Co (GMO)'s ASH Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Ashland (ASH) in Q2 2021, closing a stake of 3,274 shares — an estimated $291K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ASH in Q4 2018 and held it in 5 quarters. The position peaked at $1.96M in Q1 2019. 309 funds tracked by Wall St. Rank hold ASH as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Ashland position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,274 Ashland shares in Q2 2021, an estimated $291K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ashland in Q4 2018 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ashland position peaked at $1.96M in Q1 2019.
  • 309 funds tracked by Wall St. Rank held Ashland as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.